Dr. Edward S. Chen, MD

Dr. Chen practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Chen's NPI, 1508816919, was assigned on May 10, 2006. Dr. Chen graduated from The Johns Hopkins University School of Medicine in 1994. Dr. Chen holds Maryland license D52468.

Dr. Chen's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Chen's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Chen is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Chen to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chen is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chen's licenses on file in 6 states: Maryland, Florida, Virginia, North Carolina, Oklahoma and Alabama.

Dmand AI lists chronic lung disease among the conditions Dr. Chen treats.

CMS data shows 353 Medicare services from Dr. Chen across 6 procedure codes in 2024, for 267 Medicare patients. Medicare paid $35,049 for them.

CMS counts 267 Medicare patients who saw Dr. Chen in 2024. The largest group is 65 to 74, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 68, with 56% women.

In 2024, Dr. Chen wrote 361 Medicare Part D claims for 103 patients. 78% of them were for generic drugs. CMS names the drug for 241 of them, across 8 drugs with 11 or more claims each, at $294,887 in total drug cost. In 2023, CMS named 170 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. CMS lists Dr. Chen as offering telehealth.

Dmand AI links 74 papers to Dr. Chen, published from 2009 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Sarcoidosis, Sarcoidosis, Pulmonary and Phenotype. Dr. Chen has published most often in Ann Am Thorac Soc. Dr. Chen's most frequent co-authors are Nisha Aggarwal Gilotra, Edward Kasper, MD and David Robert Moller, MD.

Dmand AI links Dr. Chen to 3 clinical trials. 1 is still active or recruiting. Conditions studied include alpha 1-Antitrypsin Deficiency, Sarcoidosis and Hypersensitivity, Delayed. University of Pittsburgh sponsors the most, 2.

CMS Open Payments shows 6 general payments to Dr. Chen from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $212.

Dmand AI lists 1 award for Dr. Chen, most recently CMS Stage 1 EHR in 2014.

Dr. Chen graduated from The Johns Hopkins University School of Medicine in 1994. Dr. Chen is a member of ACCP and ATS.

Dr. Chen is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.